Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer
Completed · Phase 2
Conditions studied: Pancreatic Cancer
In brief
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and irinotecan, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and radiation therapy in treating patients who have locally advanced, unresectable pancreatic cancer.
Key facts
- Study ID
- NCT00025168
- Run by
- Wake Forest University Health Sciences
- People needed
- 20
- Starts
- 2001-11-01
- Expected to finish
- 2003-08-29
- Last updated by the study team
- 2021-09-09
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Lineberger Comprehensive Cancer Center, UNC — Chapel Hill, North Carolina, United States
- Southeastern Medical Oncology Center — Goldsboro, North Carolina, United States
- East Carolina University School of Medicine — Greenville, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University — Winston-Salem, North Carolina, United States
- Hollings Cancer Center at Medical University of South Carolina — Charleston, South Carolina, United States
- Greenville Hospital System — Greenville, South Carolina, United States
- Spartanburg Regional Healthcare System — Spartanburg, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.